Related Experiment Video
Updated: May 5, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Characterizing ligands for farnesoid X receptor--available in vitro test systems for farnesoid X receptor modulator
Daniel Merk1, Dieter Steinhilber, Manfred Schubert-Zsilavecz
1Goethe-University Frankfurt, Institute of Pharmaceutical Chemistry , Max-von-Laue-Str. 9, D-60438 Frankfurt am Main , Germany merk@pharmchem.uni-frankfurt.de.
Introduction:
Farnesoid X receptor (FXR) is an ascending target for metabolic and inflammatory diseases. As a nuclear receptor, FXR exhibits many physiological effects in transcription control of several genes. Therefore, the development of synthetic FXR ligands requires elaborate in vitro test systems to characterize novel ligands and to estimate their in vivo activities.
Areas Covered:
This work gathers and describes published in vitro test systems for FXR ligands including cell-based functional assays as well as binding assays. It also evaluates the information which can be provided by these assays.
Expert Opinion:
In vitro screening of FXR ligands widely relies on reporter gene assays. Additionally, some co-activator re-cruitment assays are described and for the characterization of potent compounds the pattern of affected target genes is evaluated by qPCR. Compared to other nuclear receptors such as PPARs the variety of test systems is quite low for FXR and might eventually not be enough to sufficiently characterize FXR targeting drug candidates.
Insights
Developing new Farnesoid X receptor (FXR) drugs requires robust in vitro tests. Current assays for FXR ligands are limited and may not fully assess drug candidates.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Farnesoid X receptor (FXR) is a key nuclear receptor involved in metabolic and inflammatory diseases.
- FXR regulates gene transcription, making it a significant therapeutic target.
Purpose of the Study:
- To review and evaluate existing in vitro test systems for characterizing Farnesoid X receptor (FXR) ligands.
- To assess the adequacy of current assays for evaluating novel FXR-targeting drug candidates.
Main Methods:
- Compilation and description of published cell-based functional assays and binding assays for FXR ligands.
- Evaluation of the information obtainable from these diverse in vitro assays.
Main Results:
- In vitro screening of FXR ligands predominantly utilizes reporter gene assays.
- Co-activator recruitment assays and quantitative PCR (qPCR) for target gene analysis are also employed.
- The range of available test systems for FXR is notably limited compared to other nuclear receptors like PPARs.
Conclusions:
- Current in vitro assays may be insufficient for comprehensive characterization of FXR-targeting drug candidates.
- Further development of diverse and robust test systems is needed for FXR ligand evaluation.
More Related Videos
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Signal Transduction: Overview
Typically, signal transduction involves three...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...